Invitae Sells Reproductive Health Assets to Natera for Up to $52.5M
What You Should Know:
– Invitae (NYSE: NVTA), a medical genetics company, announced the completion of its sale of certain reproductive health assets, including carrier screening and non-invasive prenatal screening (NIPS), to Natera (NASDAQ: NTRA).
–…
Continue Reading